Summary & Overview
CPT 64493: Lumbar/Sacral Facet Joint Injection with Image Guidance
CPT code 64493 is a widely utilized procedure in interventional pain management, representing the injection of a diagnostic or therapeutic agent into the lumbar or sacral paravertebral facet joint or associated nerves, with image guidance. This code is significant nationally due to its role in treating chronic back pain and other spinal disorders, which are prevalent across diverse patient populations. The procedure is most often performed in outpatient settings, such as physician offices or hospital outpatient departments.
Major payers covering this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a comprehensive overview of payer coverage, clinical indications, and policy updates relevant to this procedure. Readers will gain insights into national benchmarks, reimbursement trends, and the clinical context for the use of 64493, including its relationship to related codes for additional levels of injection. The summary also addresses common modifiers and associated taxonomies, offering a clear understanding of how this code fits within broader pain management practices. This information is essential for stakeholders seeking to navigate the evolving landscape of interventional pain management billing and policy.
CPT Code Overview
CPT code 64493 describes the injection of a diagnostic or therapeutic agent into the paravertebral facet (zygapophyseal) joint or the nerves innervating that joint in the lumbar or sacral region, performed at a single level. This procedure utilizes image guidance, such as fluoroscopy or CT, to ensure accurate placement. It is commonly used in interventional pain management and anesthesia to address chronic back pain and related conditions. The typical site of service for this procedure is an outpatient facility setting, including physician offices or hospital outpatient departments.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult presenting with chronic low back pain localized to the lumbar or sacral region. The pain is suspected to originate from the facet (zygapophyseal) joints, often due to conditions such as spondylosis or other specified dorsopathies. After conservative treatments have failed, the provider, typically in an outpatient facility setting (such as an office or hospital outpatient department), performs an image-guided injection of a diagnostic or therapeutic agent into the paravertebral facet joint or the nerves innervating that joint at a single lumbar or sacral level. The procedure is performed by a specialist in pain medicine or interventional pain management, using fluoroscopy or CT guidance to ensure accurate placement of the injection.
Coding Specifications
-
Modifier
50: Used when the procedure is performed bilaterally at the same level, indicating injections on both sides of the spine. -
Modifier
KX: Indicates that requirements specified in the medical policy have been met, commonly used for diagnostic injections.
| Modifier Code | Description |
|---|---|
50 | Bilateral procedure at same level |
KX | Medical policy requirements met (diagnostic injections) |
- Provider Taxonomies:
| Taxonomy Code | Specialty |
|---|---|
2084P0809X | Pain Medicine |
207K00000X | Interventional Pain Management |
Related Diagnoses
-
M47.816: Spondylosis without myelopathy or radiculopathy, lumbar region- Indicates degenerative changes in the lumbar spine without nerve root or spinal cord involvement, often causing facet joint pain.
-
M47.897: Other spondylosis, lumbosacral region- Refers to other types of spondylosis affecting the lumbosacral area, which may contribute to facet joint dysfunction and pain.
-
M53.86: Other specified dorsopathies, lumbar region- Encompasses other specified disorders of the lumbar spine, relevant when facet joint pathology is suspected.
-
M53.87: Other specified dorsopathies, lumbosacral region- Includes other specified disorders of the lumbosacral spine, supporting the clinical indication for facet joint injections.
Related CPT Codes
-
64494: Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint), with image guidance (fluoroscopy or CT), lumbar or sacral; second level- Used when injections are performed at a second lumbar or sacral level during the same session. Commonly billed together with
64493when more than one level is treated.
- Used when injections are performed at a second lumbar or sacral level during the same session. Commonly billed together with
-
64495: Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint), with image guidance (fluoroscopy or CT), lumbar or sacral; third and any additional level(s)- Used when injections are performed at a third or additional lumbar or sacral levels. Typically used in conjunction with
64493and64494for multi-level procedures.
- Used when injections are performed at a third or additional lumbar or sacral levels. Typically used in conjunction with
These codes are commonly used together in clinical workflows when multiple facet joints require injection during the same encounter. Each code corresponds to a specific level treated, ensuring accurate coding for multi-level procedures.
National Reimbursement Benchmarks
Nationally, the mean rate for CPT code 64493 under Medicare is $197.64, while the BUCA (average commercial) mean rate is $213.73. This indicates that commercial payers, on average, reimburse at a higher rate than Medicare for this procedure.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. UnitedHealth Group shows the widest spread at $142.17, suggesting significant variability in contracted rates. In contrast, Medicare has the tightest range at $22.00, reflecting more consistent reimbursement levels. Blue Cross Blue Shield and Aetna also display relatively narrow ranges, while Cigna's dispersion is moderate.
The table and chart below present a detailed breakdown of national benchmarks for each payer, including mean rates and percentile values.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.